The DEA (the US agency that controls which drugs are legal and illegal) says it won't move psychedelics into a less restricted category in 2026. The DEA only reshuffles drug categories after the FDA (the US drug regulator) formally approves a drug as medicine — and that hasn't happened yet. This means psychedelics stay in the most restricted legal category for another year.
Absent FDA approval, there's no scheduling trigger. My division sees normalization risks daily. We will not move ahead of a completed medical review.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →